Work

Immunotherapy advances in pleural mesothelioma

Year: 2026

Type: article

Abstract: Mesothelioma is a rare cancer that carries a poor prognosis. This malignancy has had few therapeutic advances prior to the introduction of immune checkpoint inhibitors. Immunotherapy is now a cornerstone of first-line treatment for pleural mesothelioma and has been shown to provide clinical benefit for relapsed or refractory patients treated with prior chemotherapy. This review article will discuss key immunotherapy trials in the scientific literature, along with challenges in the application of this therapy. We will also discuss future areas of immunotherapy research in the treatment of mesothelioma.

Source: Therapeutic Advances in Medical Oncology

DOI: 10.1177/17588359261420028

Authors: Annie L. Zhang, Melinda L. Hsu

Institutions: University Hospitals of Cleveland, University Hospitals Seidman Cancer Center, Case Western Reserve University

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,800